Author:
Finglas P M,de Meer K,Molloy A,Verhoef P,Pietrzik K,Powers H J,van der Straeten D,Jägerstad M,Varela-Moreiras G,van Vliet T,Havenaar R,Buttriss J,Wright A J A
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference65 articles.
1. Afman LA, Trijbels FJM, Blom HJ (2003). The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J Nutr 133, 75–77.
2. Baker F, Picton D, Blackwood S, Hunt J, Erskine M, Dyas M et al. (2002). Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial. Circulation 106, 3642 (abstract).
3. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al. (1999). Prevention of neural tube defects with folic acid in China. China–U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341, 1485–1490.
4. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P et al. (2005). International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ, doi: 19.1136/bmj.38336.664352.82 (published 18 February 2005).
5. Brouwer IA, van Dusseldorp M, West CE, Steegers-Theunissen RPM (2001). Bioavailability and bioefficacy of folate and folic acid in man. Nutr Res Rev 14, 267–293.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献